Identification of novel targets for the diagnosis and treatment of liver fibrosis
Paolo Fagone(University of Catania), Ferdinando Nicoletti(University of Catania), Antonio Pesce(University of Catania), AURORA PESCE(University of Catania), Santa Mammana(University of Catania), Katia Mangano(University of Catania), Rosario Caltabiano(University of Catania), Alexandra Giorlandino(University of Catania), Giuseppe A. G. Lombardo(University of Catania), Stefano Puleo(Istituto di Studi sul Mediterraneo (CNR - ISMed)), Marinella Coco(University of Catania), Teresa Rosanna Portale(University of Catania), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo)
Cited by 46
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495